MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Continuous dopaminergic treatment with levodopa/carbidopa intestinal gel in multiple system atrophy: report of three patients

    S. Delalic, S. Ibrulj, N. Zupancic, D. Flisar, M. Trost, Z. Pirtosek, M. Kojovic (Ljubljana, Slovenia)

    Objective: To evaluate the effect of continuous dopaminergic treatment with levodopa/carbidopa intestinal gel (LCID) on motor and non-motor symptoms in multiple system atrophy (MSA) patients.…
  • 2019 International Congress

    Plasma-based circulating long non-coding RNA AS-Uch1 as a novel diagnostic biomarker for Parkinson’s disease

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aimed to validate plasma-based circulating long non-coding RNA (lncRNA) as biomarker for the diagnosis of Parkinson's disease (PD). Background: Parkinson's disease (PD) is…
  • 2019 International Congress

    Bilateral INO in PSP

    H. Gupta (Overland Park, KS, USA)

    Objective: We describe and demonstrate a patient with PSP who had bilateral internuclear ophthalmoplegia (BINO) with intact convergence on exam. Background: A thorough eye movement…
  • 2019 International Congress

    NEUROPSYCHIATRIC SYMPTOMS IN EARLY TO ADVANCED PATIENTS WITH THE RICHARDSON’S SYNDROME VARIANT OF PROGRESIVE SUPRANUCLEAR PALSY

    A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Marin-Lahoz, J. Perez-Perez, I. Aracil-Bolanos, H. Bejr-Kasem, A. Campolongo, C. Izquierdo, F. Sampedro, J. Kulisevsky (Barcelona, Spain)

    Objective: To know prevalence of neuropsychiatric symptoms in Progressive Supranuclear Palsy along disease stages. Background: Neuropsychiatric symptoms are common features in patients with Progressive Supranuclear Palsy…
  • 2019 International Congress

    Cerebellar involvement in progressive supranuclear palsy and corticobasal degeneration

    S. Jo, KW. Park, N. Choi, CS. Lee, MS. Kim (Seoul, Republic of Korea)

    Objective: To investigate cerebellar involvement in vivo in patients with corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) using [18F]FDG PET. Background: Cerebellar ataxia is…
  • 2019 International Congress

    Impact of overweight and obesity on functional and clinical outcomes of early Parkinson’s disease

    R. Kim, JS. Jun (Seoul, Republic of Korea)

    Objective: To determine whether being overweight or obese contributes to disease progression and functional status in Parkinson’s disease (PD). Background: While the tendency of PD…
  • 2019 International Congress

    Early postural instability is an effective predictor of future freezing of gait in Parkinson’s disease

    J. Lee (Goyang-Si, Republic of Korea)

    Objective: This prospective cohort study investigated the potential predictor of future FOG occurrence in patients with de novo PD. Background: Freezing of gait (FOG) is…
  • 2019 International Congress

    Fall History and Gait Variability can Predict Falls in Individuals With Parkinson’s Disease

    L. Ma, P. Chan (Beijing, China)

    Objective: To understand the risk factors for falls in PD patients; To explore clinical indicators and Mobility Lab parameters that can predict falls in patients…
  • 2019 International Congress

    Comparison of motor, non motor symptoms, impulse control disorders and quality of life in patients with young versus late onset Parkinson’s disease

    S. Meka, R. Kandadai, T. Syed, R. Borgohain (Hyderabad, India)

    Objective: To look at the motor and non motor symptoms in patients with young onset and late onset Parkinson's disease from an indian population. Background: Parkinson’s disease is…
  • 2019 International Congress

    Phenotypic spectrum of Progressive Supranuclear Palsy in a Tunisian cohort

    A. Nasri, A. Neji, I. Kacem, T. Lansari, S. Mrabet, A. Gargouri, M. Ben Djebara, R. Gouider (Tunis, Tunisia)

    Objective: To describe the clinical and imaging features of the different phenotypes of progressive supranuclear palsy (PSP). Background: PSP is a neuropathologically defined disease entity…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley